HBV 诱导的 HCC 中的表观遗传重编程与 T 细胞耗竭及其对精准治疗的启示
Epigenetic rewiring and T cell exhaustion in HBV-induced HCC with implications for precision therapies.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ALL SOURCES
全部资讯 7
把在研试验和前沿论文合在一起看，按时间倒序排列。本页条数 = 前沿论文 + 临床试验两块之和（导航里的「临床试验」板块只收在招的那部分，不另计入）。
HBV 抗原作为 HBV 相关 HCC 过继性 TCR-T 细胞治疗中的肿瘤抗原：原理与临床有效性
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectiveness.
评估过继转移工程化 TCR-T 细胞体内多功能性的快速方法
A rapid method to assess the in vivo multi-functionality of adoptively transferred engineered TCR T cells.
免疫抑制药物耐药装甲 T 细胞在全血中针对循环 HBV 相关 HCC 的裂解效率
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood.
肝细胞癌：局限期与晚期疾病的当前治疗策略
Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease.
mRNA 电转 HBV-TCR T 细胞治疗 HBV-HCC
HBV-HCC treatment with mRNA electroporated HBV-TCR T cells.
短寿命 HBV-TCR T 细胞免疫治疗后的免疫学改变与 HBV-HCC 长期治疗应答相关
Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCC.
共 7 条